Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 127-137

  Van De Water, André ^a   D'Aubioul, Jan ^a   Van Gerven, Willy ^a   Van Ammel, Karel ^a   De Clerck, Fred ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Alniditan; Carotid arterial resistance; Ergotarnine; Sumatriptan

Indexed keywords

ALNIDITAN; ERGOTAMINE; R 091274; SEROTONIN 1 RECEPTOR; SUMATRIPTAN; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

AIRWAY RESISTANCE; ANESTHESIA; ANIMAL EXPERIMENT; ARTERIOVENOUS FISTULA; ARTICLE; CAROTID ARTERY FLOW; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG POTENCY; FEMALE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; LUNG VASCULAR RESISTANCE; MALE; MESENTERY BLOOD FLOW; NONHUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030003463     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00848-9     Document Type: Article

References (27)

1. Cambridge, D., L.J. Butterfield and H.V. Whiting, 1992, Sumatriptan stimulates nitric oxide release in vivo, in: 2nd International Symposium on Serotonin from Cell Biology to Pharmacology and Therapeutics, Houston, USA, September 15-18, Abstract p. 20.
2. Delaney, J. and J. Scarpino, 1973, Limb arteriovenous shunting following sympathetic denervation, Surgery 73, 202.
3. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan, Br. J. Pharmacol. 102, 323.
4. Den Boer, M.O., J.A.E. Somers and P.R. Saxena, 1992a, Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig, Br. J. Pharmacol. 107, 577.
5. 1D receptors involved?, Naunyn-Schmied. Arch. Pharmacol. 345, 509.
6. Feniuk, W., P.P.A. Humphrey and A.D. Watts, 1981, Modification of the vasomotor actions of melhysergide in the femoral bed of the anaesthetized dog by changes in sympathetic nerve activity, J. Auton. Pharmacol. 1, 127.
7. Feniuk, W., P.P.A. Humphrey and M.J. Perren, 1989, The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs, Br. J. Pharmacol. 96, 83.
8. 1-like agonists in the treatment of migraine, J. Neurol. 238, S38.
9. Friberg, L., J. Olesen, H.K. Iversen and B. Sperling, 1991, Migraine pain associated with middle cerebral dilatation: reversal by sumatriptan, Lancet 338, 13.
10. Hales, J.R.S., 1974, Radioactive microsphere techniques for the studies of the circulation, Clin. Exp. Pharmacol. Physiol. Suppl. 1, 31.
11. 1-like receptor agonist, GR43175, Cephalalgia 9 (Suppl. 9), 23.
12. Johnston, B.M. and P.R. Saxena, 1978, The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head, Br. J. Pharmacol. 63, 541.
13. Milliken, G.A. and D.E. Johnson (eds.), 1984, in: Analysis of Messy Data (Wadsworth, Belmont, CA) p. 473.
14. Perren, M.J., W. Feniuk and P.P.A. Humphrey, 1989, The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175, Cephalalgia 9 (Suppl, 9), 41.
15. 1D subtype, Br. J. Pharmacol. 102, 191.
16. Saxena, P.R., 1974, Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect, Eur. J. Pharmacol. 27, 99.
17. Saxena, P.R., 1986, Pharmacology of cranial arteriovenous anastomoses, in: Neuronal Regulation of Brain Circulation, eds. C. Owman and J.E. Hardebo (Elsevier, Amsterdam) p. 541.
18. Saxena, P.R. and M.O. Den Boer, 1991, Pharmacology of antimigraine drugs, J. Neurol. 238, S28.
19. Saxena, P.R. and P.D. Verdouw, 1982, Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow, J. Physiol. 332, 501.
20. Saxena, P.R., N.A. Koedam, J. Heiligers and R.P. Hof, 1983, Ergotamine-induced constriction of cranial arteriovenous anastomes in dogs pretreated with phentolamine and pizotifen, Cephalalgia 3, 71.
21. Schamhardt, H.C., P.D. Verdouw, T.M. van der Hoek and P.R. Saxena, 1979, Regional myocardial perfusion and wall thickness and arteriovenous shunting after ergotamine administration to pigs with a fixed coronary stenosis, J. Cardiovasc. Pharmacol. 1, 673.
22. Siegel, S., 1956, Nonparametric Statistics for the Behavioral Sciences (McGraw-Hill Kogakusha, Tokyo) p. 96, p. 116.
23. Spence, R.J., B.A. Rhodes and H.N. Wagner, 1972, Regulation of arteriovenous anastomotic and capillary blood flow in the dog leg, Am. J. Physiol. 222, 326.
24. Takahashi, T., J. Hisa and S. Satoh, 1992, Serotonin-induced vasoconstriction in dog kidney, J. Cardiovasc. Pharmacol. 20, 779.
25. Thompson, D.S., C.B. Waldron, S.M. Juul, N. Naqvi, R.H. Swanton, D.J. Coltart, B.S. Jenkins and M.M. Webb-Peploe, 1982, Analysis of left ventricular pressure during isovolumic relaxation in coronary artery disease, Circulation 65, 690.
26. Van de Water, A., R. Xhonneux, R.S. Reneman and P.A.J. Janssen, 1992, Cardiac and hemodynamic effects of intravenous R 80 122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure, J. Cardiovasc. Pharmacol. 20, 18.
27. Villalon, C.M., A.H. Bom, M.O. Den Boer, J.P.C. Heiligers and P.R. Saxena, 1992, Effects of S9977 and dihydroergotamine in an animal experimental model for migraine, Pharmacol. Res. 25, 125.